Cargando…
Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells
Activating mutations of MYD88 (MYD88(L265P) being the far most frequent) are found in most cases of Waldenström macroglobulinemia (WM) as well as in various aggressive B-cell lymphoma entities with features of plasma cell (PC) differentiation, such as activated B-cell type diffuse large B-cell lymph...
Autores principales: | Ouk, Catherine, Roland, Lilian, Gachard, Nathalie, Poulain, Stéphanie, Oblet, Christelle, Rizzo, David, Saintamand, Alexis, Lemasson, Quentin, Carrion, Claire, Thomas, Morgane, Balabanian, Karl, Espéli, Marion, Parrens, Marie, Soubeyran, Isabelle, Boulin, Mélanie, Faumont, Nathalie, Feuillard, Jean, Vincent-Fabert, Christelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129569/ https://www.ncbi.nlm.nih.gov/pubmed/34017329 http://dx.doi.org/10.3389/fimmu.2021.641692 |
Ejemplares similares
-
Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice
por: Vincent-Fabert, Christelle, et al.
Publicado: (2019) -
Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
por: Vincent-Fabert, Christelle, et al.
Publicado: (2019) -
A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia
por: Chauzeix, Jasmine, et al.
Publicado: (2020) -
Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell Lymphomas
por: Lemasson, Quentin, et al.
Publicado: (2021) -
c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells
por: David, Amandine, et al.
Publicado: (2017)